Journal of the Neurological Sciences
Volume 200, Issue 1 , Pages 11-18 , 15 August 2002

N-methyl-d-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease

  • Hong Bi

      Affiliations

    • Xian Jiao-Tong University, Xian, 710061, People's Republic of China
    • ,
  • Chun-I Sze

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-303-315-5314; fax: +1-303-315-4792
    • Department of Pathology, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Campus Box B216, Denver, CO 80262, USA

Received 11 December 2001 ,Revised 14 March 2002 ,Accepted 1 April 2002.

References 

  1. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361:31–39
  2. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623–634
  3. Choi DW. Excitotoxic cell death. J. Neurobiol. 1992;23:1261–1276
  4. Onley JW. Excitatory transmitter neurotoxicity. Neurobiol. Aging. 1994;15:259–260
  5. Mattson MP, Guo ZH, Geiger JD. A secreted form of amyloid precusor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosome by a cyclic GMP-mediated mechanism. J. Neurochem. 1999;73:532–537
  6. Koh J, Yang LL, Cotman CW. β-amyloid protein increase the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 1990;533:315–320
  7. Nakanishi S, Masu M, Bessho Y, Nakajima Y, Hayashi Y, Shigemoto R. Molecular diversity of glutamate receptors and their physiological functions. EXS. 1994;71:71–80
  8. Greenamyre TJ, Penny JB, D'Amato CJ, Young AB. Dementia of the Alzheimer's type: changes in hippocampal l-[3H] glutamate binding. J. Neurochem. 1987;543:51
  9. Gedds JW, Chang-Chui H, Cooper SM, Lott IT, Cotman CW. Density and distribution of NMDA receptor in the human hippocampal in Alzheimer's disease. Brain Res. 1986;399:156–161
  10. Ulas J, Cotman CW. Decreased expression of N-methyl-d-aspartate receptor 1 messenger RNA in select regions of Alzheimer brain. Neurosci. 1997;79:973–982
  11. Monaghan DT, Geddes JW, Yao D, Chung C, Cotman CW. [3H]TCP binding sites in Alzheimer's disease. Neurosci. Lett. 1987;73:197–200
  12. Tang YP, Shimizu E, Dube GR, Kerchner GA, Zhuo M, Lin G, et al.  Genetic enhancement of learning and memory in mice. Nature. 1999;401:63–69
  13. Mirra SS, Heyman A, McKeel D, et al.  The Consortium to Establish a Registry for Alzheimer's disease (CERAD): II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology. 1991;41:479–486
  14. Yoshika A, Ikegaki N, Williams M, et al.  Expression of N-methyl-d-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cell lines. J. Neurosci. 1996;46:164–172
  15. Zhang L, Hsu JC, Takagi N, et al.  Transient global ischemia alters NMDA receptor expression in rat hippocampus: correlation with decreased immunoreactive protein levels of NR2A/2B subunits, and an altered NMDA receptor functionality. J. Neurochem. 1997;69:1984–1994
  16. Foldes RL, Rampersad V, Kamboj RK. Cloning and sequence analysis of cDNAs encoding human hippocampus N-methyl-d-aspartate receptor subunits: evidence for alternative RNA splicing. Gene. 1993;131:293–298
  17. Foldes RL, Adams SL, Fantaske RP, Kamboj RK. Human N-methyl-d-aspartate receptor modulatory subunit hNR2A: cloning and sequencing of the cDNA and primary structure of the protein. Biochim. Biophys. Acta. 1994;1223:155–159
  18. Adams SL, Foldes RL, Kamboj RK. Human N-methyl-d-aspartate receptor modulatory subunit hNR3: cloning and sequencing of the cDNA and primary structure of the protein. Biochim. Biophys. Acta. 1995;1260:105–108
  19. Sze CI, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ. NMDA receptor subunit NR1, NR2A, and NR2B proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J. Neurol. Sci. 2001;182:151–159
  20. Hyman BT, Van Hosen G, Kromer LJ, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 1986;20:472–481
  21. Aoki C, Venkatesan C, Go CG, Mong JA, Dawson TM. Cellular and subcellular localization of NMDA-R1 subunit immunoreactivity in the visual cortex of adult and neonatal rats. J. Neurosci. 1994;14:5202–5222
  22. Siegel SJ, Brose N, Janssen WG, Gasic GP, Jahn R, Heinemann SF. Regional, cellular, and ultrastructural distribution of N-methyl-d-aspartate receptor subunit 1 in monkey hippocampus. Proc. Natl. Acad. Sci. 1994;91:564–568
  23. Leonard SS, Logel J, Luthman D, Casanova M, Kirch D, Freedman R. Biological stability of mRNA isolation from human postmortem brain collections. Biol. Psychiatry. 1993;33:456–466
  24. Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ. Loss of presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 1997;56:933–944
  25. Sze CI, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brain. J. Neurol. Sci. 2000;175:81–90
  26. Bobinski M, de Leon MJ, Tarnawski M, Wegiel J, Reisberg B, Miller DC, et al.  Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer's disease. Brain Res. 1998;805:267–269
  27. Laurie D, Seeburg PH. Regional and development heterogeneity in splicing of the rat brain NMDAR1 mRNA. J. Neurosci. 1994;14:3180–3194
  28. Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science. 1997;278:412–419
  29. Gomez-Isla T, Price JL, Mckeel DW, et al.  Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 1996;16:4491–4500
  30. Zhong J, Carrozza DP, Williams K, Pritchett DB, Molinoff PB. Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J. Neurochem. 1995;64:531–559
  31. Akazawa C, Shigemoto R, Bessho Y, Nakanishi S, Mizuno N. Differential expression of five N-methyl-d-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J. Comp. Neurol. 1994;347:150–160
  32. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 1994;12:529–540
  33. Hyman BT, Van Hoesen GW, Damasio AR. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann. Neurol. 1987;22:37–40
  34. Kreutz MR, Böckers TM, Bockmann J, Seidenbecher CI, Kracht B, Vorwerk CK, et al.  Axonal injury alters alternative splicing of the retinal NR1 receptor: the preferential expression of the NR1b isoforms is crucial for retinal ganglion cell survival. J. Neurosci. 1998;18:8278–8291
  35. Philpot BD, Weisberg MP, Ramos MS, Sawtell NB, Tang YP, Tsien JZ, et al.  Effect of transgenic overexpression of NR2B NMDA receptor function and synaptic plasticity in visual cortex. Neuropharmacology. 2001;41:762–770
  36. Clayton DA, Browning MD. Deficits in the expression of the NR2B subunit in the hippocampus of aged Fisher 344 rats. Neurobiol. Aging. 2001;22:165–168

PII: S0022-510X(02)00087-4

Journal of the Neurological Sciences
Volume 200, Issue 1 , Pages 11-18 , 15 August 2002

Article Tools

* Image Usage & Resolution